e-learning
resources
European Respiratory Review
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Update on biology and management of mesothelioma
Rachelle Asciak, Vineeth George, Najiib M. Rahman
Source:
Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020
Journal Issue:
March
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rachelle Asciak, Vineeth George, Najiib M. Rahman. Update on biology and management of mesothelioma. Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Contemporary management of malignant mesothelioma
Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases
Year: 2004
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014
Keynote lecture: Introduction: Treatment options and tumour biology of malignant pleural mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011
Malignant mesothelioma: new treatment advances, including targeted therapies
Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Year: 2021
Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
Update on the management of bronchiectasis
Source: International Congress 2017 – Non-CF bronchiectasis in children
Year: 2017
New molecular-directed therapies for mesothelioma: have there been any advances?
Source: International Congress 2014 – Mesothelioma: a never-ending story
Year: 2014
Approaches to radiological staging of mesothelioma relating to modern treatment modalities
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
Milestones in the management of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Malignant pleural mesothelioma: new treatments, new hopes?
Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Year: 2017
Advances in the therapeutical management of IPF
Source: Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis
Year: 2012
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Source: Eur Respir Rev 2015; 24: 115-131
Year: 2015
Translational therapeutics in pleural malignancies
Source: ERS Skills course - Medical thoracoscopy
Year: 2017
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019
Year: 2020
Malignant pleural mesothelioma: Current status and future projections in Turkey
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Prognostic impact of histology and treatment modalities in malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Update on management of ARDS
Source: Annual Congress 2013 –ME10 Update on management of ARDS
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept